ANIK
Anika Therapeutics Inc
NASDAQ: ANIK · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$12.39
-18.81% today
Updated 2026-04-29
Market cap
$165.66M
P/E ratio
—
P/S ratio
1.47x
EPS (TTM)
$-0.79
Dividend yield
—
52W range
$8 – $16
Volume
0.1M
Anika Therapeutics Inc (ANIK) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $62.62M | $68.11M | $79.50M | $95.82M | $130.70M | $128.94M | $132.84M | $142.07M | $156.04M | $194.00M | $235.75M | $240.25M | $282.62M | $278.99M | $330.71M | $365.61M | $347.54M | $349.13M | $270.63M | $202.74M |
| Cash & equivalents | $44.75M | $47.17M | $35.90M | $43.19M | $24.43M | $28.20M | $35.78M | $44.07M | $63.33M | $100.16M | $110.71M | $104.26M | $133.26M | $89.04M | $157.46M | $95.82M | $94.39M | $86.33M | $68.74M | $55.63M |
| Current assets | $52.41M | $57.61M | $52.44M | $55.83M | $49.80M | $56.32M | $64.14M | $77.38M | $94.59M | $139.03M | $176.43M | $170.44M | $206.33M | $202.94M | $234.31M | $177.38M | $168.53M | $169.55M | $163.31M | $113.65M |
| Total liabilities | $24.73M | $22.63M | $24.54M | $35.06M | $48.56M | $43.75M | $38.08M | $33.14M | $20.41M | $15.90M | $24.90M | $17.47M | $19.13M | $15.38M | $42.33M | $93.20M | $60.45M | $63.56M | $58.37M | $48.75M |
| Current liabilities | $5.83M | $5.46M | $10.64M | $9.03M | $16.53M | $19.37M | $14.54M | $14.45M | $9.28M | $5.97M | $17.28M | $8.80M | $13.07M | $11.29M | $16.28M | $36.87M | $29.80M | $27.91M | $31.06M | $23.31M |
| Long-term debt | — | — | — | $14.40M | $12.80M | $11.20M | $9.60M | $8.00M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Shareholder equity | $37.89M | $45.49M | $54.96M | $60.76M | $82.14M | $85.19M | $94.76M | $108.93M | $135.63M | $178.10M | $210.85M | $222.77M | $263.49M | $263.61M | $288.38M | $272.40M | $287.08M | $285.56M | $212.26M | $153.99M |
| Retained earnings | $3.51M | $8.12M | $14.15M | $17.78M | $21.47M | $25.79M | $34.25M | $46.01M | $66.58M | $104.90M | $135.66M | $168.21M | $199.51M | $218.23M | $245.43M | $221.44M | $225.58M | $210.72M | $128.05M | $71.67M |
| Accounts receivable | $2.07M | $3.51M | $5.80M | $5.42M | $11.83M | $14.82M | $17.31M | $21.46M | $18.74M | $17.15M | $21.65M | $27.60M | $23.82M | $20.77M | $23.08M | $24.10M | $29.84M | $34.63M | $26.36M | $23.59M |
| Inventory | $3.27M | $5.40M | $4.39M | $5.52M | $8.44M | $8.95M | $7.30M | $8.28M | $11.00M | $12.41M | $14.94M | $15.98M | $22.04M | $21.30M | $22.00M | $46.21M | $36.01M | $39.77M | $24.43M | $23.81M |
| Goodwill | — | — | $995098.00 | $936275.00 | $7.65M | $9.09M | $8.88M | $9.07M | $9.44M | $8.34M | $7.48M | $7.21M | $8.22M | $7.85M | $7.69M | $8.41M | $7.78M | $7.34M | $7.57M | $7.13M |